Protease inhibitors in carcinogenesis: possible sites of action.
D000818:Animals; D001665:Binding Sites / Q000187:drug effects; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D004790:Enzyme Induction / Q000187:drug effects; D007249:Inflammation / Q000201:enzymology; D009361:Neoplasm Invasiveness; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000201:enzymology*; D009374:Neoplasms, Experimental / Q000201:enzymology; D010447:Peptide Hydrolases / Q000378:metabolism; D010703:Phorbol Esters / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology*
D010703:Phorbol Esters; D011480:Protease Inhibitors; D010447:Peptide Hydrolases